1 |
LIANG Y. Pathogenicity and virulence of influenza[J]. Virulence,2023, 14(1): 2223057.
|
2 |
ARRANZ R, COLOMA R, CHICHÓN F J, et al. The structure of native influenza virion ribonucleoproteins[J]. Science, 2012,338(6114): 1634-1637.
|
3 |
WISE H M, HUTCHINSON E C, JAGGER B W, et al. Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain[J]. PLoS pathogens, 2012,8(11): e1002998.
|
4 |
KUMAR G, SAKHARAM K A. Tackling influenza A virus by M2 ion channel blockers: Latest progress and limitations[J]. European journal of medicinal chemistry, 2024, 267: 116172.
|
5 |
MAIR C M, LUDWIG K, HERRMANN A, et al. Receptor binding and pH stability-how influenza A virus hemagglutinin affects hostspecific virus infection[J]. Biochimica et biophysica acta, 2014,1838(4): 1153-1168.
|
6 |
LAMB R A, CHOPPIN P W. The gene structure and replication of influenza virus[J]. Annual review of biochemistry, 1983, 52: 467-506.
|
7 |
GANTI K, HAN J, MANICASSAMY B, et al. Rab11a mediates cell-cell spread and reassortment of influenza A virus genomes via tunneling nanotubes[J]. PLoS pathogens, 2021, 17(9): e1009321.
|
8 |
CHOU Y Y, HEATON N S, GAO Q, et al. Colocalization of different influenza viral RNA segments in the cytoplasm before viral budding as shown by single-molecule sensitivity FISH analysis[J]. PLoS pathogens, 2013, 9(5): e1003358.
|
9 |
ZHAO L, PENG Y, ZHOU K, et al. New insights into the nonconserved noncoding region of the subtype-determinant hemagglutinin and neuraminidase segments of influenza A viruses[J].Journal of virology, 2014, 88(19): 11493-11503.
|
10 |
OCTAVIANI C P, OZAWA M, YAMADA S, et al. High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses[J]. Journal of virology, 2010,84(20): 10918-10922.
|
11 |
ROSSMAN J S, LAMB R A. Influenza virus assembly and budding[J].Virology, 2011, 411(2): 229-236.
|
12 |
LI X, GU M, ZHENG Q, et al. Packaging signal of influenza A virus[J]. Virology journal, 2021, 18(1): 36.
|
13 |
SHAFIUDDIN M, BOON A C M. RNA sequence features are at the core of influenza a virus genome packaging[J]. Journal of molecular biology, 2019, 431(21): 4217-4228.
|
14 |
GERBER M, ISEL C, MOULES V, et al. Selective packaging of the influenza A genome and consequences for genetic reassortment[J].Trends in microbiology, 2014 , 22(8): 446-455.
|
15 |
BANCROFT C T, PARSLOW T G. Evidence for segment-nonspecific packaging of the influenza a virus genome[J]. Journal of virology,2002, 76(14): 7133-7139.
|
16 |
DADONAITE B, GILBERTSON B, KNIGHT M L, et al. The structure of the influenza A virus genome[J]. Nature microbiology,2019, 4(11): 1781-1789.
|
17 |
HARRIS A, CARDONE G, WINKLER D C, et al. Influenza virus pleiomorphy characterized by cryoelectron tomography[J].Proceedings of the National Academy of Sciences of the United States of America, 2006, 103(50): 19123-19127.
|
18 |
LOWEN A C. It's in the mix: Reassortment of segmented viral genomes[J]. PLoS pathogens, 2018, 14(9): e1007200.
|
19 |
FUJII Y, GOTO H, WATANABE T, et al. Selective incorporation of influenza virus RNA segments into virions[J]. Proceedings of the national academy of sciences of the United States of America, 2003,100(4): 2002-2007.
|
20 |
COBBIN J C, ONG C, VERITY E, et al. Influenza virus PB1 and neuraminidase gene segments can cosegregate during vaccine reassortment driven by interactions in the PB1 coding region[J].Journal of virology, 2014, 88(16): 8971-8980.
|
21 |
TCHATALBACHEV S, FLICK R, HOBOM G. The packaging signal of influenza viral RNA molecules[J]. RNA, 2001, 7(7): 979-989.
|
22 |
FLICK R, HOBOM G. Interaction of influenza virus polymerase with viral RNA in the 'corkscrew' conformation[J]. The journal of general virology, 1999, 80 (Pt 10): 2565-2572.
|
23 |
DESSELBERGER U, RACANIELLO V R, ZAZRA J J, et al. The 3'and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity[J].Gene, 1980, 8(3): 315-328.
|
24 |
BAE S H, CHEONG H K, LEE J H, et al. Structural features of an influenza virus promoter and their implications for viral RNA synthesis[J]. Proceedings of the National Academy of Sciences of the United States of America, 2001, 98(19): 10602-10607.
|
25 |
龙云凤. H3N2 亚型流感病毒Vero 细胞冷适应株遗传重配研究[D].北京:北京协和医学院, 2015.
|
26 |
DENG S, LIU Y, TAM R C, et al. An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters[J]. Nature communications, 2023, 14(1): 2081.
|
27 |
LIEW F, TALWAR S, CROSS A, et al. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination[J]. EBioMedicine, 2023, 87:104402.
|
28 |
LUND F E, RANDALL T D. Scent of a vaccine[J]. Science, 2021,373(6553): 397-399.
|
29 |
GAO Q. CHOU Y Y, DOĞANAY S, et al. The influenza A virus PB2, PA, NP, and M segments play a pivotal role during genome packaging[J]. Journal of virology, 2012, 86(13): 7043-7051.
|
30 |
HOFFMANN E, STECH J, GUAN Y, et al. Universal primer set for the full-length amplification of all influenza A viruses[J]. Archives of virology, 2001, 146(12): 2275-2289.
|
31 |
HOFFMANN E, NEUMANN G, KAWAOKA Y, et al. A DNA transfection system for generation of influenza A virus from eight plasmids[J]. Proceedings of the National Academy of Sciences of the United States of America, 2000, 97(11): 6108-6113.
|
32 |
SONG W, WANG P, MOK B W, et al. The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication[J]. Nature communications, 2014, 5: 5509.
|
33 |
ABRAHAM M, BEAVIS A C, XIAO P, et al. Evaluation of a new viral vaccine vector in mice and rhesus macaques: J paramyxovirus expressing hemagglutinin of influenza A virus H5N1[J]. Journal of virology, 2021, 95(22): e0132121.
|
34 |
HAMILTON J R, VIJAYAKUMAR G, PALESE P. A recombinant antibody-expressing influenza virus delays tumor growth in a mouse model[J]. Cell reports, 2018, 22(1): 1-7.
|
35 |
FOX A, QUINN K M, SUBBARAO K. Extending the breadth of influenza vaccines: Status and prospects for a universal vaccine[J].Drugs, 2018, 78(13): 1297-1308.
|
36 |
BU L, CHEN B, XING L, et al. Generation of a pdmH1N1 2018 influenza A reporter virus carrying a mCherry fluorescent protein in the PA segment[J]. Frontiers in cellular and infection microbiology,2022, 11: 827790.
|
37 |
RAJÃO D S, PÉREZ D R. Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture[J].Frontiers in microbiology, 2018, 9: 123.
|
38 |
CHENG X, ZENGEL J R, SUGUITAN A L, et al. Evaluation of the humoral and cellular immune responses elicited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets[J]. The journal of infectious diseases, 2013,208(4): 594-602.
|
39 |
COX A, BAKER S F, NOGALES A, et al. Development of a mouseadapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine[J]. Journal of virology, 2015, 89(6): 3421-3426.
|
40 |
KUMAR A, MELDGAARD T S, BERTHOLET S. Novel platforms for the development of a universal influenza vaccine[J]. Frontiers in immunology, 2018, 9: 600.
|
41 |
LI S, YE A, SINGH H. Effect of seasonal variations on the acid gelation of milk[J]. Journal of dairy science, 2020, 103(6): 4965-4974.
|